Detalhe da pesquisa
1.
Novel insights into metabolic-associated steatotic liver disease preclinical models.
Liver Int
; 44(3): 644-662, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291855
2.
Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD.
Liver Int
; 43(9): 1909-1919, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37288714
3.
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function.
J Hepatol
; 76(1): 11-24, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34555423
4.
Long non-coding RNA H19 as a biomarker for hepatocellular carcinoma.
Liver Int
; 42(6): 1410-1422, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35243752
5.
Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients.
Int J Mol Sci
; 23(19)2022 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36233142
6.
Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models.
Rev Esp Enferm Dig
; 111(4): 301-307, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30896960
7.
miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
J Hepatol
; 69(6): 1335-1348, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30142428
8.
Navigating the Link Between Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome.
Eur Cardiol
; 19: e03, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38807856
9.
Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis.
Biomark Res
; 11(1): 46, 2023 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37106416
10.
Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool.
Biomark Res
; 10(1): 35, 2022 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35614516
11.
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation.
Sci Rep
; 12(1): 3418, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35232986
12.
Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases.
Front Immunol
; 12: 667354, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34899679
13.
Hepatitis C Virus Clearance by Direct-Acting Antivirals Agents Improves Endothelial Dysfunction and Subclinical Atherosclerosis: HEPCAR Study.
Clin Transl Gastroenterol
; 11(8): e00203, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32955194